| Model Name | Description |
| HCC1937 | The HCC1937 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, treatment-resistant breast tumors and evaluate targeted therapies. |
| MDA-MB-436 | The MDA-MB-436 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, metastatic breast tumors and test novel therapies. |
| SUM-52PE | The SUM-52PE xenograft model is derived from human breast cancer and is used to study hormone receptor-positive tumors and evaluate targeted treatments. |
| JIMT-1 | The JIMT-1 xenograft model is derived from human HER2-positive breast cancer and is used to study trastuzumab-resistant tumors and test alternative therapies. |
| MDA-MB-361 | The MDA-MB-361 xenograft model is derived from human HER2-positive breast cancer and is used to study metastatic tumors and evaluate targeted therapies. |
| HCC-70 | The HCC-70 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, basal-like tumors and test new treatments. |
| SUM 159PT | The SUM-159PT xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, invasive tumors and evaluate experimental therapies. |
| HCC1428 | The HCC1428 xenograft model is derived from human estrogen receptor-positive breast cancer and is used to study hormone-responsive tumors and test endocrine therapies. |
| MT-3 | The MT-3 xenograft model is derived from human breast cancer and is used to study metastatic and treatment-resistant tumors. |
| DU4475 | The DU4475 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, metastatic tumors and evaluate novel therapies. |
| BT-20 | The BT-20 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive tumors and test new anticancer treatments. |
| MFM-223 | The MFM-223 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, treatment-resistant tumors and evaluate experimental therapies. |
| HCC1187 | The HCC1187 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, basal-like tumors and test new treatments. |
| HCC1569 | The HCC1569 xenograft model is derived from human HER2-positive breast cancer and is used to study aggressive tumors and evaluate targeted therapies. |
| HCC1599 | The HCC1599 xenograft model is derived from human triple-negative breast cancer and is used to study aggressive, basal-like tumors and test novel therapies. |
| BT-483 | The BT-483 xenograft model is derived from human estrogen receptor-positive breast cancer and is used to study hormone-responsive tumors and evaluate endocrine therapies. |
| HCC1500 | The HCC1500 xenograft model is derived from human estrogen receptor-positive breast cancer and is used to study hormone-responsive tumors and test targeted therapies. |
| SUM149PT | The SUM149PT xenograft model is derived from human triple-negative inflammatory breast cancer and is used to study aggressive, treatment-resistant tumors and evaluate novel therapies. |